Romiplostim for the treatment of glioblastoma-related paraneoplastic autoimmune thrombocytopenia refractory to conventional therapy.
Rodríguez-Lobato, Luis Gerardo
Romiplostim for the treatment of glioblastoma-related paraneoplastic autoimmune thrombocytopenia refractory to conventional therapy. [electronic resource] - Annals of hematology Mar 2016 - 665-6 p. digital
Publication Type: Case Reports; Letter
1432-0584
10.1007/s00277-016-2600-7 doi
Glioblastoma--complications
Humans
Male
Middle Aged
Platelet Count--trends
Purpura, Thrombocytopenic, Idiopathic--diagnosis
Receptors, Fc--therapeutic use
Recombinant Fusion Proteins--therapeutic use
Thrombopoietin--therapeutic use
Treatment Outcome
Romiplostim for the treatment of glioblastoma-related paraneoplastic autoimmune thrombocytopenia refractory to conventional therapy. [electronic resource] - Annals of hematology Mar 2016 - 665-6 p. digital
Publication Type: Case Reports; Letter
1432-0584
10.1007/s00277-016-2600-7 doi
Glioblastoma--complications
Humans
Male
Middle Aged
Platelet Count--trends
Purpura, Thrombocytopenic, Idiopathic--diagnosis
Receptors, Fc--therapeutic use
Recombinant Fusion Proteins--therapeutic use
Thrombopoietin--therapeutic use
Treatment Outcome